GWM
TGTX icon

Gilpin Wealth Management’s TG Therapeutics TGTX Stock Holding History

Gilpin Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.56K Hold
28
– – ﹤0.01% 632
2026
Q2 		$1.54K Buy
28
+5
+22% +$205 ﹤0.01% 460
2026
Q1 		$765 Buy
23
+20
+667% +$596 ﹤0.01% 524
2025
Q4 		$90 Buy
+3
New +$98 ﹤0.01% 854

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AWM
Avaii Wealth Management Appleton, Wisconsin $348M AUM 25.11% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
NWMP
Noble Wealth Management PBC Greenwood Village, Colorado $223M AUM 7.64% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return

Gilpin Wealth Management's TGTX Position: Q3 2026 in Review

Gilpin Wealth Management held its TG Therapeutics (TGTX) position steady in Q3 2026 at 28 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Gilpin Wealth Management first reported a position in TGTX in Q4 2025 and has held it in 4 quarters since. 12 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Gilpin Wealth Management held 28 shares of TG Therapeutics worth $1.56K as of Q3 2026.
  • Gilpin Wealth Management left its TG Therapeutics share count unchanged in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #632 holding.
  • Gilpin Wealth Management first reported a position in TG Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 12 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.